Welcome and introductions
Fernando López-Ríos
Navigating NSCLC: Oncologists’ perspective on biomarker testing needs
Francesco Passiglia
When tissue is the issue – optimizing liquid biopsy testing in NSCLC
Fernando López-Ríos
Insights from in-house: evaluating the impact of ultra-fast NGS on patient outcomes
Morten Grauslund
Q&A and panel discussion
All Speakers
Closing remarks
Fernando López-Ríos
Fernando López-Ríos
Hospital Universitario 12
De Octubre, Madrid, Spain
Francesco Passiglia
University of Turin,
Turin, Italy
Morten Grauslund
Copenhagen University Hospital, Copenhagen, Denmark
Visit the Thermo Fisher Scientific Booth
The time to informed treatment decisions is critical for oncology patients. The Oncomine Dx Express Test can deliver results in less than 24 hours, allowing laboratories to combine molecular biomarker results with immunohistochemistry into one complete report. Our medical and product experts will be available to discuss our solutions for genomic profiling.
VISIT US AT BOOTH NO. 2:A2
Nicola Normanno MD
Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute—Fondazione G. Pascale, Naples, Italy
Luca Quagliata PhD, BCMAS
Vice President and Global Head of Medical Affairs, Thermo Fisher Scientific
Paul Hofman MD, PhD
Professor of Pathology, Laboratory of Clinical and Experimental Pathology at Louis Pasteur Hospital, Nice, France
